Sfoglia per Rivista UNITED EUROPEAN GASTROENTEROLOGY JOURNAL
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care
2020-01-01 Saibeni, S; Scucchi, L; Dragoni, G; Bezzio, C; Miranda, A; Ribaldone, Dg; Bertani, A; Bossa, F; Allocca, M; Buda, A; Mocci, G; Soriano, A; Mazzuoli, S; Bertani, L; Baccini, F; Loddo, E; Privitera, Ac; Sartini, A; Viscido, A; Grossi, L; Casini, V; Gerardi, V; Ascolani, M; Ruscio, Md; Casella, G; Savarino, E; Stradella, D; Pumpo, R; Cortelezzi, Cc; Daperno, M; Ciardo, V; Nardone, Om; Caprioli, F; Vitale, G; Cappello, M; Comberlato, M; Alvisi, P; Festa, S; Campigotto, M; Bodini, G; Balestrieri, P; Viola, A; Pugliese, D; Armuzzi, A; Fantini, Mc; Fiorino, G; IG-IBD (Italian Group for the study of Inflammatory Bowel, Disease)
Difference in treatment outcomes between clinical trials and "real-life" clinical practice: ustekinumab in ulcerative colitis
2020-01-01 Pugliese, D; Armuzzi, A
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease
2019-01-01 Guidi, L; Pugliese, D; Panici Tonucci, T; Bertani, L; Costa, F; Privitera, G; Tolusso, B; Di Mario, C; Albano, E; Tapete, G; Gremese, E; Papa, A; Gasbarrini, A; Rapaccini, Gl; Armuzzi, A
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre
2020-01-01 Scaldaferri, F; Pugliese, D; Privitera, G; Onali, S; Lopetuso, Lr; Rizzatti, G; Settanni, Cr; Pizzoferrato, M; Schiavoni, E; Turchini, L; Amatucci, V; Napolitano, D; Bernabei, T; Mora, V; Laterza, L; Papa, A; Guidi, L; Rapaccini, Gl; Gasbarrini, A; Armuzzi, A
Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study
2021-01-01 Festa, S; Scribano, Ml; Pugliese, D; Bezzio, C; Principi, M; Ribaldone, Dg; Allocca, M; Mocci, G; Bodini, G; Spagnuolo, R; Vernia, P; Mazzuoli, S; Costa, F; Barberio, B; Cosintino, R; Zerboni, G; Aratari, A; Armuzzi, A; Papi, C
Multiple, zonal and multi-zone adenoma detection rates according to quality of cleansing during colonoscopy.
2017-01-01 Pontone, S; Hassan, C; Maselli, R; Pontone, P; Angelini, R; Brighi, M; Patrizi, G; Pironi, D; Magliocca, Fm; Filippini, A.
Risk factors for complications after ileocolonic resection for Crohn's disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study.
2017-01-01 Yamamoto, T; Spinelli, A; Suzuki, Y; Saad-Hossne, R; Teixeira, Fv; de Albuquerque, Ic; da Silva, Rn; de Barcelos, If; Takeuchi, K; Yamada, A; Shimoyama, T; da Silva Kotze, Lm; Sacchi, M; Danese, S; Kotze, Pg
Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study
2021-01-01 Goessens, L; Colombel, Jf; Outtier, A; Ferrante, M; Sabino, J; Judge, C; Saeidi, R; Rabbitt, L; Armuzzi, A; Domenech, E; Michalopoulos, G; Cremer, A; García-Alonso, Fj; Molnar, T; Karmiris, K; Gecse, K; Van Oostrom, J; Löwenberg, M; Farkas, K; Atreya, R; Ribaldone, Dg; Selinger, C; Hoentjen, F; Bihin, B; Sebastian, S; European COMBIO study, Group; Rahier, Jf
Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD study
2021-01-01 Pugliese, D; Privitera, G; Rogai, F; Variola, A; Viola, A; Laterza, L; Privitera, Ac; Allocca, M; Bossa, F; Cappello, M; Daperno, M; Lorenzon, G; Mazzuoli, S; Principi, M; Sablich, R; Moser, L; Ferronato, A; Traini, S; Tapete, G; Bodini, G; Di Girolamo, M; Grossi, L; Mocci, G; Ricci, C; Saibeni, S; Festa, S; Spagnuolo, R; Cortelezzi, Cc; Mocciaro, F; Rizzello, F; Armuzzi, A; Italian Group for the Study of Inflammatory Bowel Disease, (IG-IBD)
Young GI angle: Should I go abroad?
2019-01-01 Lobatón, T; Armuzzi, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care | 1-gen-2020 | Saibeni, S; Scucchi, L; Dragoni, G; Bezzio, C; Miranda, A; Ribaldone, Dg; Bertani, A; Bossa, F; Allocca, M; Buda, A; Mocci, G; Soriano, A; Mazzuoli, S; Bertani, L; Baccini, F; Loddo, E; Privitera, Ac; Sartini, A; Viscido, A; Grossi, L; Casini, V; Gerardi, V; Ascolani, M; Ruscio, Md; Casella, G; Savarino, E; Stradella, D; Pumpo, R; Cortelezzi, Cc; Daperno, M; Ciardo, V; Nardone, Om; Caprioli, F; Vitale, G; Cappello, M; Comberlato, M; Alvisi, P; Festa, S; Campigotto, M; Bodini, G; Balestrieri, P; Viola, A; Pugliese, D; Armuzzi, A; Fantini, Mc; Fiorino, G; IG-IBD (Italian Group for the study of Inflammatory Bowel, Disease) | |
| Difference in treatment outcomes between clinical trials and "real-life" clinical practice: ustekinumab in ulcerative colitis | 1-gen-2020 | Pugliese, D; Armuzzi, A | |
| Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease | 1-gen-2019 | Guidi, L; Pugliese, D; Panici Tonucci, T; Bertani, L; Costa, F; Privitera, G; Tolusso, B; Di Mario, C; Albano, E; Tapete, G; Gremese, E; Papa, A; Gasbarrini, A; Rapaccini, Gl; Armuzzi, A | |
| Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre | 1-gen-2020 | Scaldaferri, F; Pugliese, D; Privitera, G; Onali, S; Lopetuso, Lr; Rizzatti, G; Settanni, Cr; Pizzoferrato, M; Schiavoni, E; Turchini, L; Amatucci, V; Napolitano, D; Bernabei, T; Mora, V; Laterza, L; Papa, A; Guidi, L; Rapaccini, Gl; Gasbarrini, A; Armuzzi, A | |
| Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study | 1-gen-2021 | Festa, S; Scribano, Ml; Pugliese, D; Bezzio, C; Principi, M; Ribaldone, Dg; Allocca, M; Mocci, G; Bodini, G; Spagnuolo, R; Vernia, P; Mazzuoli, S; Costa, F; Barberio, B; Cosintino, R; Zerboni, G; Aratari, A; Armuzzi, A; Papi, C | |
| Multiple, zonal and multi-zone adenoma detection rates according to quality of cleansing during colonoscopy. | 1-gen-2017 | Pontone, S; Hassan, C; Maselli, R; Pontone, P; Angelini, R; Brighi, M; Patrizi, G; Pironi, D; Magliocca, Fm; Filippini, A. | |
| Risk factors for complications after ileocolonic resection for Crohn's disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study. | 1-gen-2017 | Yamamoto, T; Spinelli, A; Suzuki, Y; Saad-Hossne, R; Teixeira, Fv; de Albuquerque, Ic; da Silva, Rn; de Barcelos, If; Takeuchi, K; Yamada, A; Shimoyama, T; da Silva Kotze, Lm; Sacchi, M; Danese, S; Kotze, Pg | |
| Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study | 1-gen-2021 | Goessens, L; Colombel, Jf; Outtier, A; Ferrante, M; Sabino, J; Judge, C; Saeidi, R; Rabbitt, L; Armuzzi, A; Domenech, E; Michalopoulos, G; Cremer, A; García-Alonso, Fj; Molnar, T; Karmiris, K; Gecse, K; Van Oostrom, J; Löwenberg, M; Farkas, K; Atreya, R; Ribaldone, Dg; Selinger, C; Hoentjen, F; Bihin, B; Sebastian, S; European COMBIO study, Group; Rahier, Jf | |
| Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD study | 1-gen-2021 | Pugliese, D; Privitera, G; Rogai, F; Variola, A; Viola, A; Laterza, L; Privitera, Ac; Allocca, M; Bossa, F; Cappello, M; Daperno, M; Lorenzon, G; Mazzuoli, S; Principi, M; Sablich, R; Moser, L; Ferronato, A; Traini, S; Tapete, G; Bodini, G; Di Girolamo, M; Grossi, L; Mocci, G; Ricci, C; Saibeni, S; Festa, S; Spagnuolo, R; Cortelezzi, Cc; Mocciaro, F; Rizzello, F; Armuzzi, A; Italian Group for the Study of Inflammatory Bowel Disease, (IG-IBD) | |
| Young GI angle: Should I go abroad? | 1-gen-2019 | Lobatón, T; Armuzzi, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile